RCMI Coordinating Center (RCMI CC) Header Logo

Constitutive Aryl Hydrocarbon Receptor Signaling in Prostate Cancer Progression.

Ghotbaddini M, Moultrie V, Powell JB. Constitutive Aryl Hydrocarbon Receptor Signaling in Prostate Cancer Progression. J Cancer Treatment Diagn. 2018; 2(5):11-16.

View in: PubMed

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support